Healthcare Holding B.V. Gilde Sells 1,196 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SIGet Free Report) major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the company’s stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $22.60, for a total value of $27,029.60. Following the transaction, the insider directly owned 2,185,914 shares in the company, valued at $49,401,656.40. This represents a 0.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

  • On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.62, for a total transaction of $15,404.22.
  • On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total transaction of $463,866.76.
  • On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $88,140.00.
  • On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
  • On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.64, for a total value of $166,132.32.
  • On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
  • On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total value of $244,155.21.
  • On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
  • On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Price Performance

Shares of SI traded down $0.20 during mid-day trading on Friday, reaching $21.07. 51,957 shares of the stock traded hands, compared to its average volume of 96,070. The company has a market cap of $438.68 million and a price-to-earnings ratio of -10.97. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $24.59. The firm has a fifty day moving average price of $21.25 and a 200 day moving average price of $16.79. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12.

Shoulder Innovations (NYSE:SIGet Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.46) by ($0.03). The business had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. As a group, equities research analysts predict that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. UBS Group lifted their price objective on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Finally, BTIG Research raised their price objective on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, August 7th. Five investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Shoulder Innovations has an average rating of “Moderate Buy” and a consensus price target of $25.50.

Check Out Our Latest Research Report on SI

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Shoulder Innovations during the 3rd quarter valued at about $28,000. Compass Financial Management LLC purchased a new stake in Shoulder Innovations in the second quarter worth about $30,000. Rhumbline Advisers bought a new stake in Shoulder Innovations during the 3rd quarter valued at approximately $54,000. California State Teachers Retirement System grew its holdings in shares of Shoulder Innovations by 412.4% during the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after acquiring an additional 2,367 shares during the period. Finally, Wells Fargo & Company MN raised its position in shares of Shoulder Innovations by 66.3% in the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after acquiring an additional 2,094 shares in the last quarter.

About Shoulder Innovations

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Featured Stories

Insider Buying and Selling by Quarter for Shoulder Innovations (NYSE:SI)

Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.